Current and historical daily PE Ratio for Natco Pharma Ltd (
) from 1995 to Jun 10 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Natco Pharma stock (BOM:524816) PE ratio as of Jun 10 2024 is 14.
More Details
Natco Pharma Ltd (BOM:524816) PE Ratio (TTM) Chart
Natco Pharma Ltd (BOM:524816) PE Ratio (TTM) Historical Data
View and export this data going back to 1995. Start your Free Trial
Total 1239
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Natco Pharma PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-10 | 14.0 | 2024-04-01 | 12.6 |
| 2024-06-07 | 14.0 | 2024-03-28 | 12.3 |
| 2024-06-06 | 13.4 | 2024-03-27 | 13.7 |
| 2024-06-05 | 13.2 | 2024-03-26 | 13.5 |
| 2024-06-04 | 12.6 | 2024-03-22 | 13.4 |
| 2024-06-03 | 12.9 | 2024-03-21 | 13.5 |
| 2024-05-31 | 12.9 | 2024-03-20 | 13.4 |
| 2024-05-29 | 13.5 | 2024-03-19 | 13.4 |
| 2024-05-28 | 13.3 | 2024-03-18 | 13.4 |
| 2024-05-27 | 13.3 | 2024-03-14 | 13.8 |
| 2024-05-24 | 13.2 | 2024-03-13 | 13.2 |
| 2024-05-23 | 13.3 | 2024-03-12 | 13.6 |
| 2024-05-22 | 13.0 | 2024-03-11 | 14.3 |
| 2024-05-21 | 12.9 | 2024-03-07 | 14.3 |
| 2024-05-17 | 12.9 | 2024-03-06 | 14.4 |
| 2024-05-16 | 12.9 | 2024-03-05 | 13.9 |
| 2024-05-15 | 12.7 | 2024-03-04 | 14.0 |
| 2024-05-14 | 12.8 | 2024-03-01 | 13.9 |
| 2024-05-13 | 12.6 | 2024-02-29 | 14.0 |
| 2024-05-10 | 12.6 | 2024-02-28 | 13.9 |
| 2024-05-09 | 12.5 | 2024-02-27 | 14.2 |
| 2024-05-08 | 12.7 | 2024-02-26 | 14.5 |
| 2024-05-07 | 12.9 | 2024-02-23 | 14.5 |
| 2024-05-06 | 13.2 | 2024-02-22 | 14.2 |
| 2024-05-03 | 13.4 | 2024-02-21 | 14.5 |
| 2024-05-02 | 13.1 | 2024-02-20 | 14.7 |
| 2024-04-30 | 13.2 | 2024-02-19 | 15.0 |
| 2024-04-29 | 13.0 | 2024-02-16 | 14.5 |
| 2024-04-26 | 13.3 | 2024-02-15 | 12.5 |
| 2024-04-25 | 13.2 | 2024-02-14 | 12.5 |
| 2024-04-24 | 12.9 | 2024-02-13 | 12.1 |
| 2024-04-23 | 13.2 | 2024-02-12 | 11.8 |
| 2024-04-22 | 13.0 | 2024-02-09 | 11.9 |
| 2024-04-19 | 12.9 | 2024-02-08 | 12.1 |
| 2024-04-18 | 12.9 | 2024-02-07 | 12.1 |
| 2024-04-16 | 12.8 | 2024-02-06 | 12.2 |
| 2024-04-15 | 12.7 | 2024-02-05 | 12.3 |
| 2024-04-12 | 12.6 | 2024-02-02 | 12.1 |
| 2024-04-10 | 12.4 | 2024-02-01 | 12.3 |
| 2024-04-09 | 12.8 | 2024-01-31 | 12.2 |
| 2024-04-08 | 12.9 | 2024-01-30 | 12.3 |
| 2024-04-05 | 12.9 | 2024-01-29 | 12.4 |
| 2024-04-04 | 12.8 | 2024-01-25 | 12.3 |
| 2024-04-03 | 12.9 | 2024-01-24 | 12.1 |
| 2024-04-02 | 12.9 | 2024-01-23 | 11.8 |
Natco Pharma Ltd (BOM:524816) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Natco Pharma Ltd
NAICS : 325412
SIC : 2834
ISIN : INE987B01026
Share Class Description:
BOM:524816: Ordinary SharesCompare
Compare
Traded in other countries / regions
NATCOPHARM.India IPO Date
1995-04-17Description
Natco Pharma Ltd is a major drug manufacturing company. Natco aims to make specialty medicines accessible to all by manufacturing niche pharmaceutical products backed by its research and development capabilities. While the vast majority of the company's revenue is generated in India, the company looks internationally for growth opportunities. The company maintains a presence in Oncology and Hepatology treatment areas. Natco's active pharmaceutical ingredient segment APIs forms a core part of the company's business. The company operates in two different business segments: pharmaceuticals and agrochemicals. Within the pharma business segment, the company drives its sales through Finished Dosage Forms and Active Pharmaceutical Ingredients.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers